Eupraxia Pharmaceuticals Inc. logo

Eupraxia Pharmaceuticals Inc. (EPRX)

Market Open
12 Jun, 15:11
NASDAQ (CM) NASDAQ (CM)
$
6. 10
+0.07
+1.1609%
$
201.88M Market Cap
- P/E Ratio
- Div Yield
10,110 Volume
- Eps
$ 6.03
Previous Close
Add Transaction
Day Range
5.96 6.25
Year Range
3.85 9.32
Want to track EPRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Eupraxia Pharmaceuticals Inc. logo
EPRX Eupraxia Pharmaceuticals Inc.
7 May 2026
-
-
Eupraxia Pharmaceuticals Inc. logo
EPRX Eupraxia Pharmaceuticals Inc.
19 Mar 2026
-
-
Eupraxia Pharmaceuticals Inc. logo
EPRX Eupraxia Pharmaceuticals Inc.
4 Nov 2025
-
-
Eupraxia Pharmaceuticals Inc. logo
EPRX Eupraxia Pharmaceuticals Inc.
8 Aug 2025
-
-
Eupraxia Pharmaceuticals Inc. logo
EPRX Eupraxia Pharmaceuticals Inc.
6 Jun 2025
-
-
Eupraxia Pharmaceuticals Inc. logo
EPRX Eupraxia Pharmaceuticals Inc.
9 Aug 2024
-
-
Eupraxia Pharmaceuticals Inc. logo
EPRX Eupraxia Pharmaceuticals Inc.
6 Jun 2024
-
-

EPRX Earnings Reports FAQ

What is the earnings per share (EPS) for EPRX?

EPS data for EPRX is currently not available, as Eupraxia Pharmaceuticals Inc has not reported recent earnings.

What is the company's earnings growth rate?

Eupraxia Pharmaceuticals Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Eupraxia Pharmaceuticals Inc has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Eupraxia Pharmaceuticals Inc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for EPRX at this time, as Eupraxia Pharmaceuticals Inc has no recent EPS data to calculate it.